Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

72 results

Sort By:

COPD Patient-Powered Research Network

Study ID: NCT02803242
Start Date: 2014-08
End Date: 2030-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75000

Intervention / Treatment

Patient Reported Outcomes

Sponsor

COPD Foundation

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Study ID: NCT05595642
Start Date: 2022-12-29
End Date: 2027-03-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1290

Intervention / Treatment

Astegolimab

Placebo

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Trial to Determine Effective Aspirin Dose in COPD

Study ID: NCT05265299
Start Date: 2023-05-16
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

48

Intervention / Treatment

Aspirin 81mg

Aspirin 162 mg

Aspirin 325mg

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Semaglutide in Advanced Lung Disease

Study ID: NCT05746039
Start Date: 2024-01-29
End Date: 2025-12-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

8

Intervention / Treatment

Semaglutide Pen Injector

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Study ID: NCT03263130
Start Date: 2017-01-01
End Date: 2027-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap

Sponsor

Gelb, Arthur F., M.D.

Source: clinicaltrials.gov

Share:
Add to list

: Vascular Function in Health and Disease

Study ID: NCT02966665
Start Date: 2008-09
End Date: 2025-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

420

Intervention / Treatment

Maximum Exercise Tests

BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate

BQ-123

Fexofenadine, Ranitidine

Angiotensin-II, Valsartan

Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine

There-123, Missya, BHC

Sponsor

Russell Richardson

Source: clinicaltrials.gov

Share:
Add to list

Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects

Study ID: NCT05239793
Start Date: 2022-11-22
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

Njoy e-cigarette

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Study ID: NCT05119556
Start Date: 2022-06-28
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

768

Intervention / Treatment

Video Telehealth Pulmonary Rehabilitation

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Study ID: NCT05025774
Start Date: 2025-03-14
End Date: 2025-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Physical activity

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

PatientSpot Formerly Known as ArthritisPower

Study ID: NCT03840928
Start Date: 2015-04-01
End Date: 2025-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40000

Intervention / Treatment
Sponsor

Global Healthy Living Foundation

Source: clinicaltrials.gov

Share:
Add to list